PARIS - Google and French pharmaceutical giant Sanofi have announced a new joint venture focused on diabetes care. Google and French pharmaceutical giant Sanofi have announced a new joint venture focused on diabetes careThe tie up between the drug maker and Verily, the health subsidiary of Google's parent company Alphabet, will focus on treatments for people living with the chronic disease. The venture, called Onduo, will initially focus on type two diabetes, the more common form of the disease. Sanofi has invested $248 million in the venture, with Verily putting in an "equivalent" amount, according to Oelrich. Verily was born out of Google's X lab and has previously partnered with other pharma giants, including Johnson & Johnson to develop surgical robots and in a bioelectronic venture with UK-based GlaxoSmithKline.

Source: Bangkok Post September 12, 2016 03:56 UTC